Denosumab-induced Hypocalcemia in Patients with Osteoporosis and Normal Renal Function
Zouheir Ibrahim Bitar,
Adnan MA Hajjiah,
Ossama Sajeh Maadarani
et al.
Abstract:Introduction:The reported hypocalcemia was low in denosumab-treated postmenopausal women with osteoporosis (0.05-1.7% to 7.4%). The major prediction factors were Vitamin D and calcium levels and renal function. Aim: To assess the rate of hypocalcemia in patients with osteoporosis treated with denosumab, with normal renal function and Vitamin D. Materials and Methods: A retrospective analysis was conducted using the medical records (2021-2022). We looked for hypocalcemia (albumin-adjusted calcium lower than 2.1… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.